India's Marksans Pharma up as unit gets nod from UK drug regulator

Marksans Pharma

02/07/2024 07:53

** Shares of Marksans Pharma  MARK.NS  up 2.1% to 167.21
rupees
    ** Pharmaceutical firm says its unit got marketing
authorisation from UK MHRA for four products
    ** Stock was down 0.8% before the announcement
    ** MARK up ~4% YTD, rival Pfizer  PFIZ.BO  up ~8% and IOL
Chemicals and Pharmaceuticals  IOLC.BO  down ~6%

 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com))